Medicine and Dentistry
Magnetic Resonance Imaging
100%
Computer Assisted Tomography
75%
Lobular Carcinoma
59%
Diseases
50%
Digital Breast Tomosynthesis
46%
Prostate Cancer
44%
Breast Cancer
42%
Digital Mammography
41%
Mammography
39%
Superior Vena Cava Syndrome
39%
BRCA Mutation
39%
Neoplasm
32%
Multiparametric Magnetic Resonance Imaging
31%
Neoadjuvant Therapy
26%
Biopsy Technique
24%
Embolization
24%
Retrospective Study
23%
Breast Imaging - Reporting And Data System
22%
Cancer Diagnosis
21%
Patient with Crohn's Disease
19%
Emergency Department
19%
Coronary Computed Tomography Angiography
19%
Aggressive Fibromatosis
19%
Sarcopenia
19%
Cancer Risk
19%
Bile Duct Dilatation
19%
Prospective Study
19%
Prostate Specific Antigen
19%
Anticoagulation
19%
Magnetic Resonance Cholangiopancreatography
19%
Adipose Tissue
19%
Thrombosis
19%
Pancreatectomy
19%
Doxorubicin
19%
Tyrosine-Kinase Inhibitor
19%
Colorectal Liver Metastasis
19%
Treatment Effect
19%
Gynecomastia
19%
Hiatus Hernia
19%
Pancreas Adenocarcinoma
19%
Positron Emission Tomography-Computed Tomography
19%
Esophagus Carcinoma
19%
Gastrointestinal Tract
19%
Polyethylene Terephthalate
19%
Microsphere
19%
Cancer Screening
19%
Right Ventricle
19%
Superficial Vein
19%
Foreign Body
19%
Scoring System
19%
Keyphrases
Prostate Cancer Screening
59%
Contrast-enhanced Mammography
59%
Invasive Lobular Carcinoma
59%
Magnetic Resonance Imaging
56%
Digital Breast Tomosynthesis
46%
Malignant Superior Vena Cava Syndrome
39%
Patient Selection
39%
Extent of Disease
39%
Multiparametric MRI (mpMRI)
32%
Computed Tomography
31%
Neoadjuvant Therapy
26%
Mutation Carriers
26%
Breast Cancer
26%
Prostate Cancer
24%
Prostate
24%
Breast Imaging
23%
Peripheral Zone
21%
Reporting System
21%
Data Systems
21%
Overall Survival
21%
Screening Mammography
19%
Intra-arterial
19%
BRCA mutation Carriers
19%
Breast Cancer Risk
19%
Curative Surgical Resection
19%
Abdominal Aortic Calcification
19%
Anticoagulation
19%
Quantitative Evaluation
19%
Prostate-specific Antigen
19%
Microsphere Embolization
19%
Multi-targeted Tyrosine Kinase Inhibitors
19%
Bile Duct Dilatation
19%
Magnetic Resonance Cholangiopancreatography
19%
Doxorubicin
19%
Intramuscular Adipose Tissue Content
19%
Within-person Research
19%
Thrombosis
19%
Treatment Effect
19%
Qualitative Evaluation
19%
Innovative Diffusion
19%
Screening Population
19%
BRCA mutation
19%
Hormonal Treatment
19%
Hiatal Hernia
19%
Abdominopelvic Computed Tomography
19%
Gynecomastia
19%
Background Parenchymal Enhancement
19%
Desmoid-type Fibromatosis
19%
Esophageal Carcinoma
19%
Age-related Changes
19%